
News|Articles|June 1, 2002
Introduction: Considering Your Quinolone Formulary Options: An overview of Ciprofloxacin and Moxifloxacin
This Formulary supplement was produced through an unrestristed educational grant from Bayer Corporation. The views and opinions in this supplement are those of the faculty and do not necessarily reflect the views of Formulary, Advanstar Communications Inc., or Advanstar Medical Education Services. Copyright 2002 Advanstar Communications Inc. All rights reserved.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Almost Half of Severe Alopecia Areata Pediatric Patients Saw Hair Regrowth on Olumiant, Study Shows | 2025 Fall Clinical Derm
2
Beyond Sotyktu: Next-Gen TYK2 Drugs Enter Late-Stage Development | Fall Clinical Derm 2025
3
Brands of Botulinum Toxin Vary in Potency and Cost But Work the Same Way | 2025 Fall Clinical Derm
4
MHE Week in Review – AAO 2025 Highlights
5



















































